Boston Scientific Endoscopy’s Post

Looking at MBS codes for TAVI Implants in Australia, it's pleasing to see the overall uptake in this therapy. Patients at Intermediate and Low surgical risk, however, don't seem to be benefitting as much as expected, with their percentage of the total implants remaining stable since the introduction of their relative codes. The key to diagnosing these patients at the Primary Care level before they become "High Risk" candidates is Auscultation. For a refresher on Auscultation technique, head to www.MEDD.com.au #Listentotheheart

For all those cryo vein bypasses that shut down in the first 90 days...

🏥 Imperative Care gets FDA approval for Zoom 6F Insert Catheters According to Imperative Care, Zoom 6F represents the first insert catheter portfolio specifically developed for ischemic stroke procedures, based on physician feedback. The portfolio includes the Zoom SIM, Zoom VRT, and Zoom VTK technologies, with unique shapes, construction, and length, to help physicians achieve faster intracranial access. Imperative Care said that its catheters are designed to be more supportive, more torque-able and longer than current vessel selection devices. Read more online: https://lnkd.in/eJ22TBhM 📰 Follow Medical Device Developments to receive the latest medical device news daily and to subscribe to our weekly newsletter #MedicalDeviceDevelopments #medicaldevices #medicalmanufacturing

BiVACOR, a clinical-stage medical device company, has announced the successful completion of the first phase of its FDA Early Feasibility Study (EFS) for the BiVACOR Total Artificial Heart (TAH). Between July and November 2024, five patients with severe biventricular heart failure were implanted with the BiVACOR TAH as a bridge to donor heart transplant. Each patient was supported by the TAH for up to a month while awaiting a donor heart. All five patients successfully received heart transplants and were subsequently discharged from the hospital. Following these positive outcomes, the U.S. Food and Drug Administration (FDA) has approved the expansion of the EFS to include an additional 15 patients, bringing the total to 20 participants. The BiVACOR TAH represents a significant advancement in artificial heart technology. Utilizing magnetic levitation (MAGLEV) technology, it features a single moving part—a magnetically suspended dual-sided rotor—that pumps blood to both the pulmonary and systemic circulations. This design aims to minimize blood trauma and eliminate mechanical wear, potentially offering a durable and reliable heart replacement solution. For more detailed information, refer to the original article on MassDevice. https://lnkd.in/gKiVYd3N #MedicalDevices #HeaialHeart #hearttransplant #artificialheart #BiVACOR

TASC D right iliac occlusion in a life-limiting claudicant. Crossed retrogradely with angled Terumo and straight catheter combination. Balloon mounted covered stenting at the top (Atrium Advanta V12) extended & overlapped distally with an uncovered self expandable stent (Smart Control). Inline flow (and internal iliac artery flow) restored.

Follow Elsa's case as she goes through an #ERCP! From access with Autotome RX to a sphincterotomy and Advanix biliary stent placement, explore the first step in her #HPB patient journey: https://lnkd.in/e6Aykv_V #BSCEMEA

Re-entry catheters can be a really life jacket and save us from complex situations, converting a technical failure into a clinical success. This time we present a CLTI patient with RC5 and a long SFA occlusion. We were not able to cross the lesion from antegrade nor retrograde, and despite multiple maneuvers we failed reentering into the true lumen. We decided to advance a 2.9 Fr Beback catheter (Bentley) from retrograde (P3) and puncturing a balloon inserted from antegrade into the subintimal space, allowing to advance the retrograde guidewire inside the balloon. We continue removing the balloon at the same time we advance the guidewire inside it, this way we achieve a through-and-through with the guidewire externalized from both approaches. Next step, 3' PTA with a 6x240mm NC Jade Balloon (OrbusNeich Medical Company Ltd., B-endo, Be Endovascular) and completed with sirolimus DCB 6x150mm (x2) Selution SLR (Cordis). #CAHU

Is there a place for drug coated balloons in the treatment arsenal for CTO lesions? Discover two cases presented by CTO expert Dr Andrew Ladwiniec from University Hospital of Leicester: 1) How would you tackle a long #CTO lesion? 2) What if the main branch cannot be wired and sub-intimal tracking and re-entry is required? Watch the replays and join the discussion! https://lnkd.in/eyQQ2kKG #PCI #DEB #DCB #SELUTIONSLR

Jason Hannon, CEO of Mainstay, breaks down the impact of ReActiv8’s recent full-body MRI conditional labeling approvals in the UK, EU, and Australia. ReActiv8 patients in these regions can now receive MRI scans with their implanted device, removing one more barrier for those who could benefit from this groundbreaking therapy. To learn more, read the full press release → https://lnkd.in/e3sFBmPJ. The MRI approvals were achieved in connection with Mainstay receiving certificates issued by its Notified Body confirming conformity with the Medical Device Regulations (MDR) of both the European Union and the United Kingdom. Specific scan conditions and safety information are provided in the ReActiv8 MRI Guidelines manuals for each territory. #mainstaymedical #reactiv8 #multifidusdysfunction #chroniclowbackpain #restorativetherapy #thinkrestorative #restorativerevolution #lowbackpain #clbp #helpingpatients #patientfocus #puttingpatientsfirst

Intravascular Lithotripsy System (IVL) ShockFast is a pretreatment solution designed to effectively crack calcified lesions and maximize stent expansion. It is a safe, effective, and easy-to-use option for vascular procedures. IVL is the only technology that can crack both medial and intimal calcium while minimizing trauma to the vessel wall. The therapy involves a series of pulses to break up the calcium. 💪 With its proven safety, efficacy, and ease of use, Shunmei Medical's Intravascular Lithotripsy System represents a breakthrough solution for effortlessly tackling vascular calcium. Contact us today to learn more about how IVL can benefit your practice. #ShunmeiMedical #VascularHealth #MedicalInnovation #IVLTech